FDA-cleared software for advanced brain tumor analyses
Powered by AI and advanced diffusion MRI, OnQ Neuro assists radiologists, oncologists, and the Tumor Board by providing objective quantification and analysis of tumor changes over time.
High- and low-grade glioma
Slice by slice tumor segmentation in DICOM format
Longitudinal disease assessment
Automated quantification and tracking of pre- and post-treatment brain tumor volumes across time
Clinical trial support
Objective tumor quantification for improved confidence and efficiency
Unique microstructure insights
Patented Restriction Spectrum Imaging (RSI) advanced diffusion technology
OnQ™ Neuro report
Comprehensive segmentation and volumetrics reporting, automatically routed to PACS.
Provides tumor boards with a time series of brain tumor volume analysis across scans. 3D volumetrics are displayed for tumor ROIs that enable more efficient and objective reviews.